Research location
Aschaffenburg
Bavaria, Germany
Advertisement
Research activity in Aschaffenburg
Bavaria, GermanyCureCurrent currently publishes aggregate city-level research activity for this location: 38 trials and 38 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Aschaffenburg
38 linked trials · page 1 of 1A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPDNCT06981078 · 2025-07-02 · 1 site observation
ACTIVE_NOT_RECRUITING
Neoadjuvant Ontruzant (SB3) in Patients With HER2-positive Early Breast Cancer: An Open-Label (NeoON)NCT05036005 · 2021-07-11 · 1 site observation
UNKNOWN
A Study to Evaluate the Effect of Dupilumab on Exercise Capacity in Adult Patients With AsthmaNCT04203797 · 2020-07-16 · 1 site observation
COMPLETED
Real-life Pan-HER-blockade With NeratinibNCT04388384 · 2020-07-02 · 1 site observation
COMPLETED
Study of Pembrolizumab With Maintenance Olaparib or Maintenance Pemetrexed in First-line (1L) Metastatic Nonsquamous Non-Small-Cell Lung Cancer (NSCLC) (MK-7339-006, KEYLYNK-006)NCT03976323 · 2019-06-28 · 1 site observation
COMPLETED
A Study of Pembrolizumab (MK-3475) With or Without Maintenance Olaparib in First-line Metastatic Squamous Non-small Cell Lung Cancer (NSCLC, MK-7339-008/KEYLYNK-008)NCT03976362 · 2019-06-28 · 1 site observation
COMPLETED
Efficacy and Safety Study of BIIB074 in Participants With Small Fiber NeuropathyNCT03339336 · 2018-05-31 · 1 site observation
TERMINATED
INTREPID: Investigation of TRELEGY Effectiveness: Usual Practice DesignNCT03467425 · 2018-04-11 · 1 site observation
COMPLETED
Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)NCT03345407 · 2017-11-28 · 1 site observation
TERMINATED
Gan & Lee Insulin Glargine Target Type (1) Evaluating ResearchNCT03371082 · 2017-10-31 · 1 site observation
COMPLETED
A Non-interventional Study for Women With HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer to Evaluate the Real-world Effectiveness of Treatment Algorithms Beginning With Ribociclib + AI/FUL, or With Endocrine Therapy or Chemotherapy as First Line TreatmentNCT06311383 · 2017-10-09 · 1 site observation
COMPLETED
Extension Study to Assess Safety and Efficacy of Mylan's Insulin Glargine and Lantus® in Type 1 Diabetes Mellitus (T1DM) PatientsNCT02666430 · 2015-12-01 · 1 site observation
COMPLETED
Therapy Management With Nab-Paclitaxel in Daily RoutineNCT02642406 · 2015-12-01 · 1 site observation
UNKNOWN
Comparison of Axillary Sentinel Lymph Node Biopsy Versus no Axillary SurgeryNCT02466737 · 2015-09-01 · 1 site observation
ACTIVE_NOT_RECRUITING
Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes MellitusNCT02465515 · 2015-07-01 · 1 site observation
COMPLETED
Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot UlcersNCT02447172 · 2015-06-01 · 1 site observation
COMPLETED
Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes MellitusNCT02229227 · 2014-11-21 · 1 site observation
COMPLETED
A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium Compared With Tiotropium in Subjects With Chronic Obstructive Pulmonary DiseaseNCT02207829 · 2014-09-01 · 1 site observation
COMPLETED
A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT02164513 · 2014-06-30 · 1 site observation
COMPLETED
Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 1 Diabetes Mellitus Patients (INSTRIDE 1)NCT02227862 · 2014-06-01 · 1 site observation
COMPLETED
A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic SubjectsNCT02135692 · 2014-05-29 · 1 site observation
COMPLETED
Study Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Inhalation Powder (FF/VI) Compared With Vilanterol Inhalation Powder (VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT02105974 · 2014-04-07 · 1 site observation
COMPLETED
Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 DiabetesNCT01864174 · 2013-06-20 · 1 site observation
COMPLETED
A Study to Determine Long-term Safety of Mepolizumab in Asthmatic SubjectsNCT01842607 · 2013-05-27 · 1 site observation
COMPLETED
Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory AsthmaNCT01691521 · 2012-10-08 · 1 site observation
COMPLETED
Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory AsthmaNCT01691508 · 2012-10-01 · 1 site observation
COMPLETED
A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Treatment of Physician's Choice in Subjects With Advanced Non-Small Cell Lung CancerNCT01454934 · 2011-12-09 · 1 site observation
COMPLETED
SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.NCT01475721 · 2011-11-18 · 1 site observation
COMPLETED
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary DiseaseNCT01316913 · 2011-03-01 · 1 site observation
COMPLETED
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary DiseaseNCT01313676 · 2011-01-25 · 1 site observation
COMPLETED
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive MedicationNCT01195662 · 2010-10-01 · 1 site observation
COMPLETED
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor BlockerNCT01137474 · 2010-07-01 · 1 site observation
COMPLETED
Asthma Exacerbation StudyNCT01086384 · 2010-02-22 · 1 site observation
COMPLETED
A 6-month Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT01053988 · 2009-10-05 · 1 site observation
COMPLETED
Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast CancerNCT00558103 · 2007-12-01 · 1 site observation
COMPLETED
Efficacy of Pioglitazone and Glimepiride Combination Therapy in Treating Subjects With Type 2 Diabetes Mellitus.NCT00770952 · 2006-12-01 · 1 site observation
COMPLETED
Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast CancerNCT00374322 · 2006-08-01 · 1 site observation
COMPLETED
Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/GlibenclamideNCT00279045 · 2000-01-03 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.